References
- Lidbeck A. Studies on the impact of Lactobacillus acidophilus on human microflora and some cancer-re-lated intestinal ecological variables [thesis]. Department of Oral Microbiology and Medical Nutrition, Karolin-ska Institute, Huddinge University Hospital, Huddinge, Sweden, 1991.
- Wannamaker LW. Perplexity and precision in the diag-nosis of streptococcal pharyngitis. Am J Dis Child 1972; 124: 352–8.
- Stjernquist-Desatnik A, Prellner K, Christiansen P. Clinical and laboratory findings in patients with acute tonsillitis. Acta Otolaryngol (Stockh) 1987; 104: 351–9.
- Strömberg A, Schwan A, Cars O. Five versus ten days treatment of group A streptococcal pharyngotonsillitis: a randomized controlled clinical trial with phe-noxymethylpenicillin and cefadroxil. Scand J Infect Dis 1988; 20: 37–46.
- Orrling A, Stjernquist-Desatnik A, Schalén C, Kamme C. Clindamycin in persisting streptococcal pharyngo-tonsillitis after penicillin treatment. Scand J Infect Dis 1994; 26: 535–41.
- Brook I. Role of beta-lactamase producing bacteria in the failure of penicillin to eradicate group A strepto-cocci. Pediatr Infect Dis J 1985; 4: 491–5.
- Kim KS, Kaplan EL. Association of penicillin toler-ance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr 1985; 107: 681–4.
- Orrling A, Stjernquist-Desatnik A, Schalén C, Kamme C. Treatment failure in streptococcal tonsillitis. An attempt to identify penicillin tolerant Streptococcus pyogenes. Scand J Infect Dis 1996; 28: 143–7.
- Sanders C, Sanders E, Harrow D. Bacterial interfer-ence: effects of oral antibiotics on the normal throat flora and its ability to interfere with group A strepto-cocci. Infect Immun 1976; 13: 808–12.
- Roos K, Grahn E, Holm SE, Johansson H, Lind L. Interfering alpha-streptococci as a protection against recurrent streptococcal tonsillitis in children. Int .1 Pedi-atr Otorhinolaryngol 1993; 25: 141–8.
- Ziemer CH, Gibson GR. An overview of probiotics, prebiotics and synbiotics in the functional food con-cept: perspectives and future strategies. Int Diary J 1998; 8: 473–79.
- Salminen S, Deighton M, Gorbach S. Lactic acid bac-teria in health and disease. In: Salminen S, von Wright A, editors. Lactic acid bacteria. New York: Marcel Dekker Inc., 1993: 237–94..
- Lidbeck A, Gustafsson J-A, Nord C-E. Impact of Lactobacillus acidophilus supplements on the oropha-ryngeal and intestinal microflora. Scand J Infect Dis 1987; 19: 531–7.
- Johansson M-L, Molin G, Jeppsson B, Nobaek S, Ahrné S, Bengmark S. Administration of different Lac-tobacillus strains in fermented oatmeal soup: in vivo colonization of human intestinal mucosa and effect on the indigenous flora. Appl Environ Microbiol 1993; 59: 15–20.
- Adlerberth I, Ahrné S, Johansson M-L, Molin G, Hansson LA, Wold A. A mannose-sensitive adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line HT-29. Appl Environ Microbiol 1996; 62: 2244–51.
- Marklinder I, Lönner C. Fermentation properties of intestinal strains of Lactobacillus, of a sour dough and of a yoghurt starter culture in an oat-based nutritive solution. Food Microbiol 1992; 9: 197–205.
- Ebenfelt A, Lundberg C. Bacterial invasion of the tonsillar tissues in acute pharyngotonsillitis and in the adenoid: a preliminary study. Clin Otolaryngol 1994; 19: 310–3.